Name: Alayna Johnson. Year: Junior. Hometown: Minneapolis, MN. Why Illinois? I actually enrolled at Illinois because of its highly-rated physics program, but I quickly realized I was more suited for the chemistry curriculum; what I especially like is that chemistry majors take a different sequence of courses than chemistry minors and other students, so we're in smaller, more rigorous classes with equally passionate students. Chemistry at Illinois was certainly not my plan, but I really feel like it's exactly where I belong.
- The 2018 School of Chemical Sciences (SCS) Teaching Awards recipients have been announced. This year’s recipients represent just a few of the large number of highly dedicated instructors in SCS.
- Steven C. Zimmerman spoke about his drug discovery efforts for myotonic dystrophy at the David Y. Gin Symposium.
- The 2015 Larine Y. Cowan Make a Difference Award for Leadership in Diversity was given to Professor Steven Zimmerman.
- Graduate students Long Luu and Lien Nguyen, with U. of I. chemistry professor Steven Zimmerman, developed drug compounds that target three pathways associated with myotonic dystrophy type 1.
- When Associate Professor of Chemical and Biomolecular Engineering Hyunjoon Kong, graduate student Cartney Smith, and colleagues set out to improve MR imaging (MRI), they turned current contrast agent technology on its head—or rather, they turned it inside out.
- A DNA-based glue has been developed by scientists at the University of Illinois, US.
- There’s hope for patients with myotonic dystrophy.
- Scott Denmark, Deborah Leckband, Thomas Rauchfuss, and Steven Zimmerman were among the first group of scientists elected Fellows of the American Chemical Society.Four chemistry faculty have been chosen for the inaugural class of the American Chemical Society Fellows.
- Researchers at the University of Illinois have designed a small molecule that blocks an aberrant pathway associated with myotonic dystrophy type 1, the most common form of muscular dystrophy.